FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283018585> ?p ?o ?g. }

• W4283018585 endingPage "364" @default.
• W4283018585 startingPage "358" @default.
• W4283018585 abstract "Cardiogenic shock (CS) is associated with significant morbidity and mortality; however, there are limited randomized data evaluating the association between sex and clinical outcomes in patients with CS. Patients with CS enrolled in the DObutamine compaREd with MIlrinone (DOREMI) trial were evaluated in this post-hoc analysis.The primary outcome was a composite of all-cause mortality, resuscitated cardiac arrest, cardiac transplant or mechanical circulatory support, non-fatal myocardial infarction, transient ischemic attack or stroke, or initiation of renal replacement therapy. Secondary outcomes included the individual components of the primary outcome. We analyzed the primary and secondary outcomes using unadjusted relative risks and performed adjusted analysis for the primary outcome and all-cause mortality using the covariates mean arterial pressure <70 mmHg at inotrope initiation, age, and acute myocardial infarction CS.Among 192 participants in the DOREMI study, 70 patients (36 %) were female. The primary outcome occurred in 38 female patients (54 %) compared to 61 male patients (50 %) [adjusted relative risk (aRR) 1.23; 95 % CI 0.78-1.95, p = 0.97]. When stratified by inotrope, there was no difference in the primary outcome comparing females to males receiving dobutamine (RR 1.14; 95 % CI 0.79-1.65, p = 0.50) nor milrinone (RR 1.03; 95 % CI 0.68-1.57, p = 0.87). There was no difference in all-cause mortality comparing females to males (aRR 1.51; 95 % CI 0.78-2.94, p = 0.88). Additionally, there were no differences in any secondary outcomes between males and females (p > 0.05 for all endpoints).In patients presenting with CS treated with milrinone or dobutamine, no differences in clinical outcomes were observed between males and females." @default.
• W4283018585 created "2022-06-18" @default.
• W4283018585 creator A5000638410 @default.
• W4283018585 creator A5001675402 @default.
• W4283018585 creator A5021975567 @default.
• W4283018585 creator A5026037761 @default.
• W4283018585 creator A5030370212 @default.
• W4283018585 creator A5037117070 @default.
• W4283018585 creator A5037471440 @default.
• W4283018585 creator A5042320984 @default.
• W4283018585 creator A5042506894 @default.
• W4283018585 creator A5060041188 @default.
• W4283018585 creator A5061915282 @default.
• W4283018585 creator A5083616613 @default.
• W4283018585 creator A5083906814 @default.
• W4283018585 creator A5088090381 @default.
• W4283018585 date "2022-10-01" @default.
• W4283018585 modified "2023-10-09" @default.
• W4283018585 title "No sex-based difference in cardiogenic shock: A post-hoc analysis of the DOREMI trial" @default.
• W4283018585 cites W1995853919 @default.
• W4283018585 cites W1999537819 @default.
• W4283018585 cites W2034185700 @default.
• W4283018585 cites W2041781505 @default.
• W4283018585 cites W2077358681 @default.
• W4283018585 cites W2140764287 @default.
• W4283018585 cites W2161601552 @default.
• W4283018585 cites W2161817226 @default.
• W4283018585 cites W2755584350 @default.
• W4283018585 cites W2791730097 @default.
• W4283018585 cites W2913249070 @default.
• W4283018585 cites W2926155689 @default.
• W4283018585 cites W2945771063 @default.
• W4283018585 cites W2955729578 @default.
• W4283018585 cites W2997178397 @default.
• W4283018585 cites W3012255738 @default.
• W4283018585 cites W3080694092 @default.
• W4283018585 cites W3090822636 @default.
• W4283018585 cites W3092768436 @default.
• W4283018585 cites W3113178943 @default.
• W4283018585 cites W3130373284 @default.
• W4283018585 cites W3137173685 @default.
• W4283018585 cites W3185231568 @default.
• W4283018585 cites W3189445947 @default.
• W4283018585 cites W3191729710 @default.
• W4283018585 cites W3192489984 @default.
• W4283018585 cites W4224066931 @default.
• W4283018585 cites W4226230371 @default.
• W4283018585 doi "https://doi.org/10.1016/j.jjcc.2022.06.001" @default.
• W4283018585 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35725945" @default.
• W4283018585 hasPublicationYear "2022" @default.
• W4283018585 type Work @default.
• W4283018585 citedByCount "2" @default.
• W4283018585 countsByYear W42830185852022 @default.
• W4283018585 countsByYear W42830185852023 @default.
• W4283018585 crossrefType "journal-article" @default.
• W4283018585 hasAuthorship W4283018585A5000638410 @default.
• W4283018585 hasAuthorship W4283018585A5001675402 @default.
• W4283018585 hasAuthorship W4283018585A5021975567 @default.
• W4283018585 hasAuthorship W4283018585A5026037761 @default.
• W4283018585 hasAuthorship W4283018585A5030370212 @default.
• W4283018585 hasAuthorship W4283018585A5037117070 @default.
• W4283018585 hasAuthorship W4283018585A5037471440 @default.
• W4283018585 hasAuthorship W4283018585A5042320984 @default.
• W4283018585 hasAuthorship W4283018585A5042506894 @default.
• W4283018585 hasAuthorship W4283018585A5060041188 @default.
• W4283018585 hasAuthorship W4283018585A5061915282 @default.
• W4283018585 hasAuthorship W4283018585A5083616613 @default.
• W4283018585 hasAuthorship W4283018585A5083906814 @default.
• W4283018585 hasAuthorship W4283018585A5088090381 @default.
• W4283018585 hasConcept C126322002 @default.
• W4283018585 hasConcept C127413603 @default.
• W4283018585 hasConcept C155710745 @default.
• W4283018585 hasConcept C164705383 @default.
• W4283018585 hasConcept C178853913 @default.
• W4283018585 hasConcept C2776645727 @default.
• W4283018585 hasConcept C2776850375 @default.
• W4283018585 hasConcept C2780645631 @default.
• W4283018585 hasConcept C2781185063 @default.
• W4283018585 hasConcept C2781300812 @default.
• W4283018585 hasConcept C44249647 @default.
• W4283018585 hasConcept C500558357 @default.
• W4283018585 hasConcept C67761136 @default.
• W4283018585 hasConcept C71924100 @default.
• W4283018585 hasConcept C78519656 @default.
• W4283018585 hasConcept C82789193 @default.
• W4283018585 hasConceptScore W4283018585C126322002 @default.
• W4283018585 hasConceptScore W4283018585C127413603 @default.
• W4283018585 hasConceptScore W4283018585C155710745 @default.
• W4283018585 hasConceptScore W4283018585C164705383 @default.
• W4283018585 hasConceptScore W4283018585C178853913 @default.
• W4283018585 hasConceptScore W4283018585C2776645727 @default.
• W4283018585 hasConceptScore W4283018585C2776850375 @default.
• W4283018585 hasConceptScore W4283018585C2780645631 @default.
• W4283018585 hasConceptScore W4283018585C2781185063 @default.
• W4283018585 hasConceptScore W4283018585C2781300812 @default.
• W4283018585 hasConceptScore W4283018585C44249647 @default.
• W4283018585 hasConceptScore W4283018585C500558357 @default.
• W4283018585 hasConceptScore W4283018585C67761136 @default.

• next